Efficacy of curcuminoids in alleviation of iron overload and lipid peroxidation in thalassemic mice

Medicinal Chemistry

Volumn 5, Issue 5, 2009, Pages 474-482

  Thephinlap, C ^a   Phisalaphong, C ^b   Fucharoen, S ^c   Porter, J B ^d   Srichairatanakool, S ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b Thailand Government Pharmaceutical Organization   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

thalassemia; Curcuminoids; Iron overload; Non transferrin bound iron; Oxidative stress

Indexed keywords

CURCUMINOID; DEFERIPRONE; GLUTATHIONE; IRON; IRON CHELATING AGENT; MALONALDEHYDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HEART MUSCLE CELL; IRON BLOOD LEVEL; IRON CHELATION; IRON OVERLOAD; LIPID PEROXIDATION; LIVER CELL; LIVER WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; THALASSEMIA;

ANIMALS; BETA-THALASSEMIA; BODY WEIGHT; CURCUMIN; GLUTATHIONE; HEMOGLOBINS; IRON; IRON CHELATING AGENTS; IRON OVERLOAD; LIPID PEROXIDATION; LIVER; MICE; ORGAN SIZE;

EID: 70349142708     PISSN: 15734064     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340609789117912     Document Type: Article

References (32)

1. Olivieri, N. F. The beta-thalassemias. N. Engl. J. Med., 1999, 341, 99.
2. Gutteridge, J. M.; Rowley, D. A.; Griffiths, E.; Halliwell, B. Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis. Clin. Sci. (Lond), 1985, 68, 463.
3. Hershko, C.; Weatherall, D. J. Iron-chelating therapy. Crit. Rev. Clin. Lab. Sci., 1988, 26, 303.
4. Hershko, C.; Konijn, A. M.; Link, G. Iron chelators for thalassaemia. Br. J. Haematol., 1998, 101, 399.
5. Kassab-Chekir, A.; Laradi, S.; Ferchichi, S.; Haj Khelil, A.; Feki, M.; Amri, F.; Selmi, H.; Bejaoui, M.; Miled, A. Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia. Clin. Chim. Acta, 2003, 338, 79.
6. Olivieri, N. F.; Brittenham, G. M. Iron-chelating therapy and the treatment of thalassemia. Blood, 1997, 89, 739.
7. Olivieri, N. F.; Brittenham, G. M.; Matsui, D.; Berkovitch, M.; Blendis, L. M.; Cameron, R. G.; McClelland, R. A.; Liu, P. P.; Templeton, D. M.; Koren, G. Iron-chelation therapy with oral deferipronein patients with thalassemia major. N. Engl. J. Med., 1995, 332, 918.
8. Zurlo, M. G.; De Stefano, P.; Borgna-Pignatti, C.; Di Palma, A.; Piga, A.; Melevendi, C.; Di Gregorio, F.; Burattini, M. G.; Terzoli, S. Survival and causes of death in thalassaemia major. Lancet, 1989, 2, 27.
9. Iancu, T. C. Ultrastructural pathology of iron overload. Baillieres Clin. Haematol., 1989, 2, 475.
10. Thakerngpol, K.; Fucharoen, S.; Boonyaphipat, P.; Srisook, K.; Sahaphong, S.; Vathanophas, V.; Stitnimankarn, T. Liver injury due to iron overload in thalassemia: histopathologic and ultrastructural studies. Biometals, 1996, 9, 177.
11. Risdon, R. A.; Flynn, D. M.; Barry, M. The relation between liver iron concentration and liver damage in transfusional iron overload in thalassaemia and the effect of chelation therapy. Gut, 1973, 14, 421.
12. Witzleben, C. L.; Wyatt, J. P. The effect of long survival on the pathology of thalassaemia major. J. Pathol. Bacteriol., 1961, 82, 1.
13. Jean, G.; Terzoli, S.; Mauri, R.; Borghetti, L.; Di Palma, A.; Piga, A.; Magliano, M.; Melevendi, M.; Cattaneo, M. Cirrhosis associated with multiple transfusions in thalassaemia. Arch. Dis. Child.,. 1984, 59, 67.
14. Ammon, H. P.; Safayhi, H.; Mack, T.; Sabieraj, J. Mechanism of antiinflammatory actions of curcumine and boswellic acids. J. Ethnopharmacol., 1993, 38, 113.
15. Sreejayan; Rao, M. N. Curcuminoids as potent inhibitors of lipid peroxidation. J. Pharm. Pharmacol., 1994, 46, 1013.
16. Aggarwal, B. B.; Kumar, A.; Bharti, A. C. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res., 2003, 23, 363.
17. Ammon, H. P.; Wahl, M. A. Pharmacology of Curcuma longa. Planta Med., 1991, 57, 1.
18. Dairam, A.; Fogel, R.; Daya, S.; Limson, J. L. Antioxidant and iron-binding properties of curcumin, capsaicin, and S-allylcysteine reduce oxidative stress in rat brain homogenate. J. Agric. Food Chem., 2008, 56, 3350.
19. Marco, B.; Erika, F.; Romano, G; Monica, S. Curcuminoids as potential new iron-chelating agents: spectroscopic, polarographic and potentiometric study on their Fe(III) complexing ability. Inorganica Chimica Acta, 2002, 328, 61.
20. Bernabe-Pineda, M.; Ramirez-Silva, M. T.; Romero-Romo, M. A.; Gonzalez-Vergara, E.; Rojas-Hernandez, A. Spectrophotometric and electrochemical determination of the formation constants of the complexes Curcumin-Fe(III)-water and Curcumin-Fe(II)-water. Spectrochim. Acta A Mol. Biomol. Spectrosc., 2004, 60, 1105.
21. Srichairatanakool, S.; Thephinlap, C.; Phisalaphong, C.; Porter, J. B.; Fucharoen, S. Curcumin contributes to in vitro removal of non-transferrin bound iron by deferiprone and desferrioxamine in thalassemic plasma. Med. Chem., 2007, 3, 469.
22. Singh, S.; Hider, R. C.; Porter, J. B. A direct method for quantification of non-transferrin-bound iron. Anal. Biochem., 1990, 186, 320.
23. Cheng, C. S.; Sullivan, T. D.; Li, P. K. Iron toxicity screening. JACEP., 1979, 8, 238.
24. Chirico, S. High-performance liquid chromatography-based thiobarbituric acid tests. Methods Enzymol., 1994, 233, 314.
25. Jamsai, D.; Orford, M.; Fucharoen, S.; Williamson, R.; Ioannou, P. A. Insertion of modifications in the beta-globin locus using GET recombination with single-stranded oligonucleotides and denatured PCR fragments. Mol. Biotechnol., 2003, 23, 29.
26. Papanastasiou, D. A.; Vayenas, D. V.; Vassilopoulos, A.; Repanti, M. Concentration of iron and distribution of iron and transferrin after experimental iron overload in rat tissues in vivo: study of the liver, the spleen, the central nervous system and other organs. Pathol. Res. Pract., 2000, 196, 47.
27. Linpisarn, S.; Satoh, K.; Mikami, T.; Orimo, H.; Shinjo, S.; Yoshino, Y. Effects of iron on lipid peroxidation. Int. J. Hematol., 1991, 54, 181.
28. Houglum, K.; Filip, M.; Witztum, J. L.; Chojkier, M. Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload. J. Clin. Invest., 1990, 86, 1991.
29. Britton, R. S. Metal-induced hepatotoxicity. Semin. Liver Dis., 1996, 16, 3.
30. Valerio, L. G., Jr.; Petersen, D. R. Characterization of hepatic iron overload following dietary administration of dicyclopentadienyl iron (Ferrocene) to mice: cellular, biochemical, and molecular aspects. Exp. Mol. Pathol., 2000, 68, 1.
31. Cheng, A. L.; Hsu, C. H.; Lin, J. K.; Hsu, M. M.; Ho, Y. F.; Shen, T. S.; Ko, J. Y.; Lin, J. T.; Lin, B. R.; Ming-Shiang, W.; Yu, H. S.; Jee, S. H.; Chen, G. S.; Chen, T. M.; Chen, C. A.; Lai, M. K.; Pu, Y. S.; Pan, M. H.; Wang, Y. J.; Tsai, C. C.; Hsieh, C. Y. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res., 2001, 21, 2895.
32. Chainani-Wu, N. Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). J. Altern. Complement Med., 2003, 9, 161.